Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mendelics | RCV000011999 | SCV001141757 | pathogenic | Duchenne muscular dystrophy | 2019-05-28 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001781237 | SCV002022804 | pathogenic | not provided | 2022-06-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000011999 | SCV003445062 | pathogenic | Duchenne muscular dystrophy | 2024-02-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln497*) in the DMD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DMD are known to be pathogenic (PMID: 16770791, 25007885). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Duchenne muscular dystrophy (PMID: 7951253). ClinVar contains an entry for this variant (Variation ID: 11247). For these reasons, this variant has been classified as Pathogenic. |
OMIM | RCV000011999 | SCV000032233 | pathogenic | Duchenne muscular dystrophy | 1993-11-01 | no assertion criteria provided | literature only |